ArticleAlzheimer's & dementia (New York, N. Y.)2022

Efficacy and safety of cilostazol in decreasing progression of cerebral white matter hyperintensities-A randomized controlled trial.

Bonaventure Y M Ip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.